Prioritization of novel druggable targets for epilepsy via Mendelian randomization and colocalization

Key Points

• Novel druggable targets for epilepsy are identified, enhancing the potential for new treatments.
• This analysis revealed targets with significant support through mendelian randomization, linking genetic variants with epilepsy.
• Mendelian randomization and colocalization were utilized to investigate genetic factors in epilepsy.
• Findings support advancing therapeutic strategies while calling for further validation studies.